BiotechTube
Home/Wicab/William A. Conn, Jr.
WA

William A. Conn, Jr.

Acting CEO

Wicab

Therapeutic Areas

Blindness & Vision ImpairmentBalance DisordersNeurological Rehabilitation

Wicab Pipeline

DrugIndicationPhase
BrainPort Vision ProProfound BlindnessApproved
BrainPort Balance PlusBalance Disorders/Vestibular RehabilitationApproved
BrainPort for Traumatic Blindness (DoD Trial)Blindness due to Traumatic InjuryClinical Trial

Leadership Team at Wicab

LM
Lara M Swiersz, CPA
Controller
PG
Patricia Grant, Ph.D.
Director of Clinical Research
D(
Daihui (Fred) Wang
Director of Operations - China
View full Wicab profile